NULL

Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Korea

Malaysia

Philippines

Vaccines

Coglavax - Reg. No. G3684 (Act 36 / 1947)

Clostridial vaccine with the following toxoids from:

1.C. perfringens against enterotoxemia:

  • Alfa (Blood gut in sheep and Red gut in cattle),
  • Beta (Lamb Dysentery in lambs),
  • Epsilon (Pulpy Kidney in sheep),

2. Alpha toxoid from novyi type B (False Blackleg, Necrotic Hepatitis, Swelled Head Disease, Maligant Oedema),

3. C. septicum (Uterine Gas Gangrene, Malignant Oedema and Gas Gangrene),

4. C. tetani (Lock jaw/ Tetanus),

5. C. chauvoei (Black quarter in cattle and sheep).

Available in:

  • 100 mL
  • 250 mL
  • 500 mL

Effectively reduces the risk of losses due to toxin production following the overgrowth of the ubiquitous Clostridial bacteria, under the following circumstances:

  • Fast growing stock with high dry matter intake,
  • After parturition in heifers, cows and ewes,
  • During sudden , high intakes of lush growing pasture,
  • Variation in intakes as is often the case in zero grazing dairy systems and beef and sheep feedlots,
  • In wounds (e.g. caused by shearing, uterine wounds, tail docking, castration and teething in young stock),
  • In times where supplementary feeding is needed as in the case of severe drought and in certain times of the production cycle.

Lower risk of injection site tissue reactions and post-administration pain at the injection site which may affect feed intake.

Target species:

  • cattle icon Cattle
  • sheep icon Sheep

Product information

How to use

Subcutaneous dose for cattle > 100 kg body mass is 4 mℓ and 2 mℓ for sheep and cattle < 100 kg body mass. Administer earliest at age 4 months and 4 weeks to calves and lambs, respectively. To be followed by a 2nd vaccination 4 – 6 weeks later in stock that have not been vaccinated before. Thereafter once annually – ideally at dry-off in dairy cows and around weaning in beef cattle; 4 – 6 weeks before anticipated lambing in ewes.

We see what you see. Cow eye

Why choose
Coglavax?

Broad protection

Multivalent protection against the main clostridial diseases.

Efficacy

Concentration of alpha toxoid (2UI per ml)

Multispecies

Protection for both cattle and sheep.

Withdrawal periods

Meat: 21 days.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.